A Phase 3 interventional study of zilebesiran in high-risk hypertensive patients

Recruiting Phase 3 NCT07181109

Study Description

A study testing whether zilebesiran can reduce heart attacks, strokes, and other cardiovascular problems in people with high blood pressure

Study Details

Registry ID:
NCT07181109
Conditions:
High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
Phase:
Phase 3
Target Enrollment:
11,000 participants
Start Date:
Healthy Volunteers:
No

Study Locations (654 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →